Published in J Immunol on March 01, 1984
Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect Immun (1991) 1.84
Lymphokine-induced inhibition of growth of Eimeria bovis and Eimeria papillata (Apicomplexa) in cultured bovine monocytes. Infect Immun (1985) 1.21
Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice. Infect Immun (1988) 0.83
Differential inhibition of macrophage microbicidal activity by liposomes. Infect Immun (1985) 0.80
Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol (1989) 4.44
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol (1990) 4.36
Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun (1991) 3.99
Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol (1990) 3.79
Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun (1992) 3.09
In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun (1992) 3.07
Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol (1988) 2.82
Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg (1994) 2.73
Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med (1993) 2.61
Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect Immun (1995) 2.52
Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages. J Immunol (1981) 2.39
Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi. J Immunol (1979) 2.34
Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol (1991) 2.30
Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science (1987) 2.11
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis (1994) 2.02
Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol (1990) 2.02
Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages. J Immunol (1981) 1.94
Host defenses in experimental scrub typhus: role of normal and activated macrophages. Infect Immun (1979) 1.76
Detection of Francisella tularensis in blood by polymerase chain reaction. J Clin Microbiol (1993) 1.75
Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser (1994) 1.73
IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J Immunol (1991) 1.73
Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J Immunol (1991) 1.71
Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis. N Engl J Med (1982) 1.68
Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect Immun (1993) 1.65
T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect Immun (1993) 1.62
Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb Pathog (1992) 1.56
Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett (1994) 1.54
Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents. J Immunol (1984) 1.54
Look-back investigation after human immunodeficiency virus seroconversion in a pediatric dentist. J Infect Dis (1994) 1.46
Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues. J Infect Dis (1976) 1.46
The threat of infectious diseases in Somalia. N Engl J Med (1993) 1.38
Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. Immunol Lett (1990) 1.36
Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line. Infect Immun (1983) 1.35
Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions. J Reticuloendothel Soc (1979) 1.31
Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg (1985) 1.31
Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities. Cell Immunol (1983) 1.29
Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am J Med Sci (1994) 1.27
Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: amastigote infection of resident cells and inflammatory exudate macrophages. Infect Immun (1982) 1.26
Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol (1989) 1.24
ELISA method for detecting Plasmodium falciparum circumsporozoite antibody. Bull World Health Organ (1989) 1.20
A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro. J Immunol (1986) 1.20
Activation of macrophages to kill rickettsiae and Leishmania: dissociation of intracellular microbicidal activities and extracellular destruction of neoplastic and helminth targets. Contemp Top Immunobiol (1984) 1.20
Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis (1995) 1.19
Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma. Cell Immunol (1985) 1.16
Dose- and time-dependent relations between infective Anopheles inoculation and outcomes of Plasmodium falciparum parasitemia among children in western Kenya. Am J Epidemiol (1997) 1.14
The threat of infectious disease in Americans returning from Operation Desert Storm. N Engl J Med (1991) 1.14
Rapid generation of specific protective immunity to Francisella tularensis. Infect Immun (1992) 1.12
Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research Group. J Acquir Immune Defic Syndr (1990) 1.11
Macrophages in resistance to rickettsial infections: early host defense mechanisms in experimental scrub typhus. Infect Immun (1981) 1.11
Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am J Trop Med Hyg (1994) 1.10
Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. Am J Trop Med Hyg (1982) 1.09
Malaria in asplenic mice: effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg (1980) 1.08
Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. N Engl J Med (1989) 1.08
Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: comparison of amastigote replication in adherent and nonadherent macrophages. Infect Immun (1981) 1.06
Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities. Cell Immunol (1983) 1.05
Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro. J Immunol (1989) 1.04
A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res (1997) 1.04
Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med (1977) 1.04
Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun (1988) 1.03
Genetic control of systemic Leishmania major infection: identification of subline differences for susceptibility to disease. Curr Top Microbiol Immunol (1985) 1.03
IL-2. A cofactor for induction of activated macrophage resistance to infection. J Immunol (1990) 1.01
Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis (1998) 1.00
Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection. J Immunol (1988) 0.99
Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis (2000) 0.99
Macrophages in resistance to rickettsial infections: protection against lethal Rickettsia tsutsugamushi infections by treatment of mice with macrophage-activating agents. J Leukoc Biol (1984) 0.98
Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J Infect Dis (1979) 0.98
Macrophages in resistance to rickettsial infection: susceptibility to lethal effects of Rickettsia akari infection in mouse strains with defective macrophage function. Cell Immunol (1980) 0.98
Detection of active tuberculosis by an MPB-64 transdermal patch: a field study. Scand J Infect Dis (2001) 0.98
Killing of Leishmania tropica amastigotes by factors in normal human serum. J Immunol (1984) 0.97
Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis. J Leukoc Biol (1993) 0.95
Plasmodium falciparum gametocytemia in Kenyan children: associations among age, intensity of exposure to transmission, and prevalence and density of subsequent gametocytemia. Am J Trop Med Hyg (1997) 0.94
Initial clinical evaluation of a new Rocky Mountain spotted fever vaccine of tissue culture origin. J Infect Dis (1978) 0.91
Isolation of Leishmania donovani from Phlebotomus martini in Baringo district, Kenya. Trans R Soc Trop Med Hyg (1988) 0.91
Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. Am J Trop Med Hyg (1983) 0.91
Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella. J Immunol (1988) 0.91
Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.90
Post kala-azar dermal leishmaniasis: the Kenyan experience. East Afr Med J (1991) 0.90
Susceptibility of inbred mice to Leishmania tropica infection: genetic control of the development of cutaneous lesions in P/J mice. J Immunol (1984) 0.90
Prophylactic treatment of Rocky Mountain spotted fever. J Clin Microbiol (1978) 0.90
Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes. J Immunol (1984) 0.89
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin Infect Dis (1998) 0.89
Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor. J Immunol (1992) 0.89
Identification of Rickettsia conorii infection by polymerase chain reaction in a soldier returning from Somalia. Clin Infect Dis (1994) 0.89
Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya. East Afr Med J (1986) 0.88
Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization. Am J Trop Med Hyg (1991) 0.87
Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae. Infect Immun (1978) 0.87
Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am J Trop Med Hyg (1993) 0.87
Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice. Infect Immun (1987) 0.87
Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro. J Immunol (1984) 0.87
Similar molecular requirements for antigen receptor-triggered secretion of interferon and granule enzymes by cytolytic T lymphocytes. Cell Immunol (1989) 0.87
Analysis of macrophage interactions with cryopreserved amastigotes of Leishmania tropica. Infect Immun (1983) 0.86
Genetic control of systemic Leishmania major infections: dissociation of intrahepatic amastigote replication from control by the Lsh gene. Infect Immun (1985) 0.84
Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg (1985) 0.84
Clinical performance of a polymerase chain reaction testing algorithm for diagnosis of HIV-1 infection in peripheral blood mononuclear cells. J Med Virol (1991) 0.83
IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. Microb Pathog (1993) 0.83
Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral Research. J Am Acad Dermatol (1993) 0.83
Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. Ann Intern Med (1978) 0.83